Cytek investor relations
WebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex’s Flow Cytometry and Imaging Business, which closed on February 28, 2024. Webcast Information WebNov 21, 2024 · Therefore, investors should monitor Cytek’s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts ...
Cytek investor relations
Did you know?
WebFeb 13, 2024 · Cytek Biosciences, Inc. Investor Conference Call Cytek will host a conference call on Monday, February 13, 2024, at 1:30 PM Pacific Time / 4:30 PM Eastern Time. A webcast of the conference call can be accessed at … WebNov 3, 2024 · These forward-looking statements should not be relied upon as representing Cytek’s views as of any date subsequent to the date of this press release. Media Contact: Stephanie Olsen Lages & Associates (949) 453-8080 [email protected] Investor Relations Contact: Carrie Mendivil/Mary Kate McDonough Gilmartin Group LLC …
Web厦泰生物WPF开发中级工程师（C#）招聘，薪资：14-18K·14薪，地点：无锡，要求：1-3年，学历：本科，福利：年终奖、定期体检、五险一金，TA Supervisor刚刚在线，随时随地直接开聊。 WebFeb 13, 2024 · An existing installed base of more than 7,000 instruments will be under the Cytek umbrella following the acquisition, expanding the company’s global commercial …
WebThe Investor Relations website contains information about Cytek Biosciences's business for stockholders, potential investors, and financial analysts. WebFeb 7, 2024 · Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and Twitter account in addition to following its SEC filings, news releases, public conference calls and webcasts.
WebCytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the …
WebApr 28, 2024 · He is a licensed Certified Public Accountant in the State of California. Investor contact: Paul D. Goodson Head of Investor Relations Cytek Biosciences … rawls graduate schoolWebFeb 13, 2024 · Cytek Biosciences is registered under the ticker NASDAQ:CTKB . Their stock opened with $17.00 in its Jul 23, 2024 IPO. … rawls golf hall of fameWebMar 7, 2024 · Cytek’s 20-Color AML Panel is an effective and sensitive flow cytometric approach for identifying and characterizing normal and aberrant cells, immunophenotyping, and evaluating measurable residual disease (MRD) in AML samples. The new panel unleashes the power of Cytek’s Full Spectrum Profiling™ (FSP™) technology – and is … simple help androidWebFeb 13, 2024 · Corporate Vice President Communication & Investor Relations Corporate Investor Relations & ESG Analyst [email protected] … rawls group facebookWebThe Investor Relations website contains information about Cytek Biosciences's business for stockholders, potential investors, and financial analysts. simplehelp black screenWebCytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Form 10-K Q3 Cytek Biosciences Third Quarter 2024 Earnings Conference Call Cytek Biosciences Reports Third Quarter 2024 Financial Results Form 10-Q Q2 Cytek Biosciences Second Quarter 2024 Earnings Conference Call rawls goodreadsWeb职位搜索 新闻资讯 BOSS直聘APP 投资者关系 Investor Relations 直品公益基金会 使用与帮助 协议与规则 隐私政策 防骗指南 使用帮助 联系BOSS直聘. 北京华品博睿网络技术有限公司. 公司地址 北京市朝阳区太阳宫中路16号院1号楼18层1801内09 simplehelp client download